STAT+: Dueling endorsements emerge for FDA commissioner: Woodcock or Sharfstein?
As the White House struggles to address the pandemic and other pressing health matters, a public tug-of-war has emerged over who should be tapped to run the Food and Drug Administration.
In recent weeks, competing missives have been issued urging the Biden administration to choose either Janet Woodcock, a long-standing FDA official who some perceive to be unnecessarily sympathetic to industry, or Joshua Sharfstein, who has also served at the agency and has a public health background, but is seen as less supportive of industry concerns.
